| Date | Title | Description |
| 13.09.2026 | Euno Secures $23M Series A: Powering AI's Understanding of Enterprise Data | Euno, the enterprise AI-native context platform, just secured $23 million in Series A funding. This boosts its total capital to $29 million. N47 spearheaded the investment. The platform empowers AI agents. It gives them deep understanding o... |
| 09.09.2026 | Euno Raises $23M to Scale Enterprise AI Context Platform | Euno Raises Series A to Advance Enterprise AI
Euno has raised $23 million in Series A funding to expand its AI context platform. The round was led by N47 with participation from existing investor 10D. Several technology founders also joined... |
| 10.12.2020 | Israeli blood test startup Sight Diagnostics inks deal for distribution in UAE | Israel’s Sight Diagnostics, a startup that analyzes blood samples with a small device in minutes, has inked a deal to install its products in the United Arab Emirates and other Gulf countries.
The company said on Wednesday it had agreed to ... |
| 13.10.2020 | The Key To Health Care's Success Post-Pandemic? Decentralization | Sarah is the CTO of Sight Diagnostics, a company transforming healthcare through fast, accurate and less painful blood testing. |
| 06.08.2020 | Sight Diagnostics, Emery Capital portfolio company, has announced the raise of US$71 million Series D round | Sight Diagnostics (https://www.sightdx.com), Israeli company developing blood testing platform based on computer vision, AI and machine learning, has announced that it raised a US$71 million Series D round. The participants of the round inc... |
| 05.08.2020 | Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach | Sight Diagnostics has raised $71 million to help expand the commercial reach of its FDA-cleared, tabletop machine for analyzing a finger-prick’s worth of blood.
Sponsored by Agilent Technologies
How would you like to win free bench space at... |
| 05.08.2020 | Sight Diagnostics : Raises $71M To Accelerate Global Expansion of its FDA 510(k) Cleared, CE Marked Finger-prick Blood Analyzer | Sight DiagnosticsⓇ, the company behind the first FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, announced today it has raised $71 million in Series D funding with participation from Koch Disruptive Technologies, Lo... |
| 05.08.2020 | Sight Diagnostics Nabs $71M to Expand FDA-Cleared Finger-Prick Blood Analyzer | What You Should Know:
– Sight Diagnostics, the company behind the first FDA-approved fingerstick Complete Blood Count analyzer, announced it has raised $71 million in Series D funding from leading strategic investors including Koch Industri... |
| 05.08.2020 | Sight Diagnostics raises $71 million for blood-testing computer vision | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Sight Diagnostics, which is deploying an AI-power... |
| 05.08.2020 | Tabletop blood tester Sight Diagnostics raises $71M to expand commercial reach | Sight Diagnostics has raised $71 million to help expand the commercial reach of its FDA-cleared, tabletop machine for analyzing a finger-prick’s worth of blood.
The Tel Aviv-based company’s series D round was backed by Koch Disruptive Techn... |
| 05.08.2020 | Sight Diagnostics hauls in $71M Series D for fingerprick blood analysis | |
| 05.08.2020 | Sight Diagnostics raises $71 million for blood-testing computer vision | Did you miss a session from GamesBeat Summit 2022? All sessions are available to stream now. Learn more.
Sight Diagnostics, which is deploying an AI-powered blood analysis machine, this week nabbed $71 million in funding. This more than dou... |
| 05.08.2020 | Sight Diagnostics raises another $71M to fully commercialize its blood analyzer | “We have a specific focus on the U.S market and are planning to ramp up commercialization as allowed by FDA 510(k) clearance,” wrote Yossi Pollak, the company’s CEO in an email response to questions that was forwarded by a representative. “... |
| 05.08.2020 | Sight Diagnostics raises $71 million for blood-testing computer vision | Sight Diagnostics, which is deploying an AI-powered blood analysis machine, this week nabbed $71 million in funding. This more than doubles the startup’s total raised, and a spokesperson says it will be used to accelerate Sight’s operations... |
| 05.08.2020 | Sight Diagnostics Raises $71M in Series D Funding | Sight Diagnostics, a Tel Aviv, Israel-based maker of an FDA-cleared direct-from-fingerstick Complete Blood Count (CBC) analyzer, raised $71m in Series D funding.
Backers included Koch Disruptive Technologies, Longliv Ventures and OurCrowd.
... |
| 05.08.2020 | Sight Diagnostics raises $71M Series D for its blood analyzer | Sight Diagnostics, the Israel-based health-tech company behind the FDA-cleared OLO blood analyzer, today announced that it has raised a $71 million Series D round with participation from Koch Disruptive Technologies, Longliv Ventures (which... |
| 28.07.2020 | Medical device startup Sight Diagnostics scores $71M | Blood testing startup Sight Diagnostics has raised $71 million from investors including Clal Biotechnology Industries. The Tel Aviv-based business is the provider of a desktop device that analyzes cartridges of patients' blood using machine... |
| 02.06.2020 | OurCrowd launches $100M Pandemic Innovation Fund to invest in tech startups that target solutions for COVID 19 and future pandemics | OurCrowd, a Jerusalem, Israel-based venture capital firm and the world’s largest crowdfunded-venture investment platform, today announced the launch of $100 million Pandemic Innovation Fund for investment in urgent technological solutions f... |
| 13.02.2020 | Interested in Investing in Early Stage Firms? OurCrowd Has a Long List, Reports 36 Exits to Date | OurCrowd is arguably the leading investment crowdfunding platform in the world. Based in Israel but listing offerings from companies around the world, OurCrowd has seen approximately $1.4 billion in committed funding since inception. Of the... |
| 04.12.2019 | FDA clearance positions Sight Diagnostics to deliver on two-drop blood testing promise | The Olo system [Image courtesy of Sight Diagnostics]Today’s news that Sight Diagnostics secured 510(k) clearance for its Olo analyzer certainly will reduce the flow of future patient tears and fears as the system requires just two drops of ... |
| 04.12.2019 | Israeli fingerprick blood testing company gets FDA clearance for CBC analyzer | The clearance allows for fingerprick testing and the more traditional venous blood draws to enable complex testing using the Olo analyzer that can now be used in laboratories run by hospitals. The regulatory action was based on data from cl... |
| 20.11.2019 | Truvian Sciences raises $27.1M for a testing system needing only “a small sample of blood” | That comparison with the now-defunct Theranos is something that the chief execute of San Diego-based Truvian Sciences is more than prepared to counter.
In response to email questions surrounding its Series B funding forwarded by a spokeswom... |
| 07.03.2019 | OurCrowd Offers New $50 Million Medtech Fund for Investors | OurCrowd, the largest investment crowdfunding platform in the world, has announced the launch of the OurCrowd Medtech Fund joining their existing portfolio of 18 funds. The $50 million fund will focus exclusively on investing in disruptive ... |
| 01.03.2019 | Term Sheet — Friday, March 1 | PAYING UP FOR CYBERSECURITY
Good morning, Term Sheet readers.
Paid Content What you need to know about growing cyberattacks From ExtraHop
The deal is being made through KKR’s $711 million Next Generation Technology Growth Fund, which target... |
| 15.02.2019 | Term Sheet — Friday, February 15 | FINDING OPPORTUNITY
Good morning, Term Sheet readers.
Paid Content Securing the enterprise without boundaries From ExtraHop
There’s been a lot of talk and interest around Opportunity Zones, a new capital gains exemption for people who make ... |
| 15.02.2019 | Medtech startup Sight Diagnostics secures €25M funding, deploys AI to speed up blood tests | Sight Diagnostics is an Israel-based medical devices startup, which uses artificial intelligence to speed up the process of blood testing. In a recent development, this startup raised $27.8 million (approximately €25 million) in Series C fu... |
| 14.02.2019 | Daily funding roundup - February 14th, 2019 | Kreatize raised $4.5M; Tank Utility raised $6M; Complion raised $7M: Sight Diagnostics raised $27.8M
Hostme: Hostme is a modern, cloud-based reservation and table management system for restaurant owners. Hostme has raised $1.3 million in fu... |
| 14.02.2019 | Sight Diagnostics raises $27.8 million to apply AI to blood tests | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today!
Blood tests are generally unpleasant — not to men... |
| 14.02.2019 | Sight Diagnostics raises $27.8 million to apply AI to blood tests | Blood tests are generally unpleasant — not to mention costly. On average, getting blood work done at a lab costs uninsured patients between $100 and $1,500. And in the developing world, where the requisite equipment isn’t always readily ava... |
| 14.02.2019 | Sight Diagnostics Raises $27.8M In Series C Funding | Sight Diagnostics, a Tel Aviv, Israel-based company working to provide patients with lab-grade blood testing results in minutes, raised $27.8m in Series C funding.
The round was led by Longliv Ventures, with participation from OurCrowd, Go ... |
| 14.02.2019 | Top startup news for today, Thursday, February 14, 2019 | Good morning and Happy Valentine’s Day! Here are some of the top technology startup news stories for today, Thursday, February 14.
AI startup Peltarion raises $20 million in Series A funding to grow and scale. Peltarion, a Stockholm, Swede... |
| 14.02.2019 | Biotech AI startup Sight Diagnostics gets $27.8M to speed up blood tests | Sight Diagnostics, an Israeli medical devices startup that’s using AI technology to speed up blood testing, has closed a $27.8 million Series C funding round.
The company has built a desktop machine, called OLO, that analyzes cartridges man... |
| 23.12.2018 | Sight Diagnostics Secures $28M Series C Financing | Israel-based Sight Diagnostics has raised $28 Million in Series C funding from Clal Biotechnology Industries.
Sight Diagnostics has developed a real-time blood test requiring only a few drops of blood that can be collected by pricking a fi... |
| 27.09.2018 | Sight Diagnostics uses computer vision to analyze blood samples | A single device that can perform a slew of tests on a prick of blood was the promise of Theranos, a diagnostics startup that was found to have misled investors about its tech’s capabilities and whose founders were recently charged with frau... |
| 13.07.2018 | Term Sheet – Friday, July 13 | EDUCATION
Happy Friday. Polina returns Monday. Reach me lucinda.shen@fortune.com.
Paid Content Securing the enterprise without boundaries From ExtraHop
Today, Austin-based pi-top, a learn-to-code startup, raised $16 million in funding led b... |
| 12.07.2018 | Sight Diagnostics starts selling an AI-based diagnostics device for faster blood tests | Sight Diagnostics, an Israeli medical devices startup that’s using computer vision and machine learning technology to speed up blood testing, is launching a point-of-care blood diagnostics system today.
It claims the compact, desktop machin... |
| - | Truvian Sciences raises $27.1M for a testing system needing only “a small sample of blood” | Truvian Sciences is developing an automated benchtop broad panel testing system on a “small sample of blood” to support which the company just raised $27.1 million.
How small? Seven drops to be precise. That’s six more than Theranos, which ... |
| - | «Disruptor 50» от CNBC — самые быстроразвивающиеся компании | «Disruptor 50» от CNBC — самые быстроразвивающиеся компании
29 Мая, 2021, 12:01
Даниил Ивженко
1228
CNBC представила свой девятый ежегодный список «2021 Disruptor 50», в котором собраны частные компании, выходящие из пандемии с быстрым темп... |
| - | Sight Diagnostics raises another $71M to fully commercialize its blood analyzer | Tel Aviv, Israel-based Sight Diagnostics, which makes a complete blood count (CBC) analyzer only requiring two drops of blood, announced Wednesday that it had raised $71 million in a Series D funding round.
The investment comes from investo... |
| - | Israeli fingerprick blood testing company gets FDA clearance for CBC analyzer | The opportunity presented in fingerprick blood testing is one that many companies are chasing.
Among these is Israeli diagnostics firm Sight Diagnostics, which announced Wednesday that the Food and Drug Administration has cleared its Olo bl... |
